| Bioactivity | MMP-9-IN-7 is a potent MMP9 inhibitor with an IC50 of 0.52 μM in proMMP9/MMP3 P126 activation assay. MMP-9-IN-7 is extracted from patent WO2012162468 (example 59), and can be used for MMP9/MMP13 mediated syndrome research[1]. |
| Name | MMP-9-IN-7 |
| CAS | 333746-76-2 |
| Formula | C16H15ClN4O2S2 |
| Molar Mass | 394.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Paul Francis Jackson, et al. Thiazol derivatives as pro -matrix metalloproteinase inhibitors. Patent WO2012162468. |
MMP-9-IN-7
CAS: 333746-76-2 F: C16H15ClN4O2S2 W: 394.90
MMP-9-IN-7 is a potent MMP9 inhibitor with an IC50 of 0.52 μM in proMMP9/MMP3 P126 activation assay. MMP-9-IN-7 is extr
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.